Personalised prostate cancer screening may save thousands from unnecessary treatment
Targeting prostate cancer screening based on a man's age and genes could potentially save thousands of men from unnecessary treatment and save the NHS millions of pounds. The research is presented at the NCRI Cancer Conference in Liverpool today (Monday).
The researchers, funded by Cancer Research UK, developed a theoretical model to compare the effectiveness and cost of two different approaches to prostate cancer screening.
The model showed that a personalised approach – based on a man's age and looking for the common genes that increase the risk of prostate cancer – would result in fewer deaths from the disease and cost tens of millions less for the NHS to roll out compared to screening all men aged 55 to 79 every four years with the PSA test.
The model also showed 50 per cent fewer men would need to be screened and 18 per cent fewer men would be diagnosed with the disease – possibly reducing the problem of over-diagnosis and saving men from unnecessary treatment that can lead to side effects like impotence and incontinence.
Men in the UK are not screened for prostate cancer as part of a national screening programme. This is because the only available test, the PSA test, is not an accurate indicator of whether a man does have cancer and cannot reliably tell if a cancer is aggressive and so needs treatment.
Instead, men who ask for a PSA test are given information by their GP to help them understand the pros and cons before they decide whether they want to go ahead with the test.
Study author Dr Nora Pashayan, a Cancer Research UK clinician scientist at University College London, said: "We don't have a screening programme for prostate cancer because the benefits are outweighed by the harms. Identifying men who are more likely to develop prostate cancer and targeting them for screening could potentially save thousands of men from overdiagnosis and unnecessary treatment. We're now refining our model to develop more definite predictions which will then need to be tested in trials to see if this approach will have the effect we predict."
Each year over 40,000 men are diagnosed with prostate cancer in the UK, with over 10,500 men dying from the disease.
Professor Peter Johnson, Cancer Research UK's chief clinician, said: "There is great uncertainty about the usefulness of screening for prostate cancer using the PSA test, with many men finding it difficult to weigh up the pros and cons. This research suggests an important way to select men for whom testing may be more worthwhile, which points us in the right direction for the future. Cancer Research UK is already funding research that is looking at targeting screening to men at a higher risk of developing the disease."
More information: www.ncri.org.uk/nc… ts/A132.html
Provided by Cancer Research UK
- Early warning: PSA testing can predict advanced prostate cancer Feb 15, 2008 | not rated yet | 0
- Should the UK lower the age for prostate cancer detection? Nov 16, 2007 | not rated yet | 0
- Recommendation against PSA test too drastic: WU expert May 22, 2012 | not rated yet | 0
- Recommendation against PSA test goes too far: expert Oct 12, 2011 | not rated yet | 0
- Early prostate cancer detection, screening: No benefit for men with low baseline PSA value Sep 13, 2010 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer 9 hours ago | not rated yet | 0
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer 9 hours ago | not rated yet | 0
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer 12 hours ago | 5 / 5 (1) | 0
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer 13 hours ago | 5 / 5 (1) | 0
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer 13 hours ago | 5 / 5 (3) | 0
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
12 hours ago | 5 / 5 (3) | 0 |
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
7 hours ago | 5 / 5 (1) | 0 |
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
9 hours ago | 5 / 5 (2) | 0 |
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
10 hours ago | 5 / 5 (2) | 0 |
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
6 hours ago | not rated yet | 0